4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-051170
Chief Medical Officer sold 12,500 shares at an average $31.90 ($398,694)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pang Phillip · Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-16 | Exercise or conversion : show line 1 in the form | +9,720 | $1.58 | $15,309 | 39,497 | D |
| 2020-09-16 | Exercise or conversion : show line 2 in the form | +465 | $1.53 | $711 | 39,962 | D |
| 2020-09-16 | Exercise or conversion : show line 3 in the form | +2,315 | $5.18 | $11,980 | 42,277 | D |
| 2020-09-16 | Sale : show line 4 in the form | −7,500 | $31.88 | $239,103 | 34,777 | D |
| 2020-09-16 | Sale : show line 5 in the form | −5,000 | $31.92 | $159,591 | 29,777 | D |
| Open-market sales · 12,500 sh · avg $31.90 · $398,694 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-16 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) | −9,720 | 53,242 | D |
| 2020-09-16 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) | −465 | 110,646 | D |
| 2020-09-16 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) | −2,315 | 69,444 | D |
Loading xslF345X03/doc4.xml…